Cochrane Colloquia
Scientific Presentations and Posters
Annual Cochrane Colloquia are held to promote and develop the work of the Collaboration, and to help shape its future direction. Many oral and poster presentations at past colloquia have been related to the methodologies of incorporating adverse effects into systematic reviews;
16th Cochrane Colloquium 2008
Biester K, Skipka G, Lange S. Interpreting intergroup differences on low quality data of adverse events (AE) in primary clinical trials of non-drug interventions. In: 16th Cochrane Colloquium; 2008 October 3-7 Freiburg, Germany. 2008.
Chen XY, Fan ZY, Zhou Y, Dong XX, Liu Y, Wan XL,Wang F, QW Zhang QW. Clinician’s basic knowledge on patient safety in China. In: 16th Cochrane Colloquium; 2008 October 3-7 Freiburg, Germany. 2008.
Golder S, Loke YK, Burch, J. Impact of funding source on reporting of adverse effects: methodological overview. In: 16th Cochrane Colloquium; 2008 October 3-7 Freiburg, Germany. 2008.
Golder S, Loke YK, Burch J. Where to identify information on adverse effects for a systematic review: a methodological overview. In: 16th Cochrane Colloquium; 2008 October 3-7 Freiburg, Germany. 2008.
Riera R, Vieira VP, Andriolo RB, Lima LG, Macedo CR, Puga MES, Silva BN, Atallah AN. Information concerning the safety and adverse effects of medical procedures reported in a Brazilian journal In: 16th Cochrane Colloquium; 2008 October 3-7 Freiburg, Germany. 2008.
Vandenbroucke JP. Balancing benefits and risks of treatment: combining the best evidence on benefit with the best evidence about harms. In: 16th Cochrane Colloquium; 2008 October 3-7 Freiburg, Germany. 2008.
15th Cochrane Colloquium 2007
Ai C, Zhang M, Li J. Adverse effects of traditional chinese medicine should be reported in Cochrane reviews. In: 15th Cochrane Colloquium; 2007 October 23-27 Sao Paulo, Brazil. 2007.
Bastian H, Schultheis A. Good news about bad news: Improvements in attention to adverse effects in Cochrane reviews (1997-2007). In: 15th Cochrane Colloquium; 2007 October 23-27 Sao Paulo, Brazil. 2007.
Kovacs Burns K, Lyddiatt A. From gloabl to local patient safety champions: collaborating on improving patient safety. In: 15th Cochrane Colloquium; 2007 October 23-27 Sao Paulo, Brazil. 2007.
Reeves BC, Herxheimer A, Wells GA, Gyte G. Describing rare and serious harms of interventions. In: 15th Cochrane Colloquium; 2007 October 23-27 Sao Paulo, Brazil. 2007.
14th Cochrane Colloquium 2006
Aronson J, Hauben M. Between-the-eyes adverse drug reactions: anecdotes as evidential gold standards In: 14th Cochrane Colloquium; 2006 October 23-26 Dublin, Ireland. 2006. Available from: http://colloquiumabstracts.cochrane.org/
Bastian H, Herxheimer A, Wieseler B. What are the characteristics of good reviews of adverse effects? A qualitative exploration In: 14th Cochrane Colloquium; 2006 October 23-26 Dublin, Ireland. 2006. Available from: http://colloquiumabstracts.cochrane.org/
Golder S, Loke Y, McIntosh H. How is information on adverse effects identified for systematic reviews? A survey of methods used from 1994-2005. In: 14th Cochrane Colloquium; 2006 October 23-26 Dublin, Ireland. 2006. Available from: http://colloquiumabstracts.cochrane.org/
Golder S, Loke Y, McIntosh H. Going beyond MEDLINE - what information might reviewers find from searching databases of adverse drug reactions. In: 14th Cochrane Colloquium; 2006 October; Dublin, Ireland.; 2006. Available from: http://colloquiumabstracts.cochrane.org/
Hopewell S, Wolfenden L, Clarke M. Reporting of adverse events in systematic reviews [abstract] In: 14th Cochrane Colloquium; 2006 October 23-26 Dublin, Ireland. 2006. p. 48. Available from: http://colloquiumabstracts.cochrane.org/
Juhl Jørgensen K. Author affiliation influences the presentation of benefits and harms of mammography screening in scientific articles In: 14th Cochrane Colloquium; 2006 October 23-26 Dublin, Ireland. 2006. Available from: http://colloquiumabstracts.cochrane.org/
Scherer R. Are harms reported in abstracts of trial results from conference proceedings? In: 14th Cochrane Colloquium; 2006 October 23-26 Dublin, Ireland. 2006. Available from: http://colloquiumabstracts.cochrane.org/
13th Cochrane Colloquium 2005
Ethgen M, Boutron I, Baron G, Giraudeau B, Sibilia J, Ravaud P. Reporting of harm in randomized controlled trials evaluating pharmacological and nonpharmacological treatments In: 13th Cochrane Colloquium; 2005 October 22-26; Melbourne, Australia. 2005. Available from: http://colloquiumabstracts.cochrane.org/
Golder S, McIntosh H, Glanville J. Searching for systematic reviews of adverse effects In: 13th Cochrane Colloquium; 2005 October 22-26; Melbourne, Australia. 2005. Available from: http://colloquiumabstracts.cochrane.org/
12th Cochrane Colloquium 2004
Golder S, Duffy S, Glanville J, McIntosh H. Developing efficient search strategies to identify papers on adverse events. B: using statistical analysis. In: 12th Cochrane Colloquium: Bridging the Gaps; 2004 October 2 -6 Ottawa, Ontario, Canada. 2004. Available from: http://www.cochrane.org/colloquia/abstracts/ottawa/O-052.htm
Golder S, Duffy S, Glanville J, McIntosh H, Miles J. Developing efficient search strategies to identify papers on adverse events. A: testing precision and sensitivity. In: 12th Cochrane Colloquium: Bridging the Gaps; 2004 October 2-6 Ottawa, Ontario, Canada. 2004. p. 75-76. Available from: http://www.cochrane.org/colloquia/abstracts/ottawa/O-053.htm
Jefferson T, Demicheli V. Including non-randomised studies in systematic reviews of vaccines safety: methodological issues [abstract]. In: 12th Cochrane Colloquium: Bridging the Gaps; 2004 October 2-6 Ottawa, Ontario, Canada. 2004. p. 77-78. Available from: http://www.cochrane.org/colloquia/abstracts/ottawa/O-056.htm
Papanikolaou P, Churchill R, Wahlbeck K, Ioannidis J. Reporting of harms in randomized trials of mental health interventions In: 12th Cochrane Colloquium: Bridging the Gaps; 2004 October 2-6; Ottawa, Ontario, Canada. 2004. p. 60-61. Available from: http://www.cochrane.org/colloquia/abstracts/ottawa/O-028.htm
Papanikolaou P, Ioannidis J. Availability of large-scale evidence on specific harms from systematic reviews of randomised trials. In: 12th Cochrane Colloquium: Bridging the Gaps; 2004 October 2-6; Ottawa, Ontario, Canada. 2004. Available from: http://www.cochrane.org/colloquia/abstracts/ottawa/O-027.htm
Vandermeer B, Wiebe N, Buscemi N, Hartling L, Klassen T. Adverse events and adverse effects in systematic reviews: some methodological issues In: 12th Cochrane Colloquium: Bridging the Gaps; 2004 October 2-6; Ottawa, Ontario, Canada. 2004. p. 199. Available from: http://www.cochrane.org/colloquia/abstracts/ottawa/P-153.htm
11th Cochrane Colloquium 2003
Als-Nielsen B, Chen W, Gluud C, Kjaergard LL. Association of funding and authors' conclusions in randomized drug trials: a reflection of treatment benefit or adverse events? In: 11th Cochrane Colloquium: Evidence, Health Care and Culture; 2003 October 26-31; Barcelona, Spain. 2003. p. 36.
Clarke A, Shakir S, Deeks J. ''Withdrawn from market'' - how comprehensive and accessible is the evidence-base for medicinal products withdrawn due to safety concern? In: 11th Cochrane Colloquium: Evidence, Health Care and Culture; 2003 October 26-31; Barcelona, Spain. 2003. p. 23.
Jefferson T, Demicheli V, Bianco E. The handling of evidence in systematic reviews of vaccines safety: methodological issues. In: 11th Cochrane Colloquium: Evidence, Health Care and Culture; 2003 October 26-31; Barcelona, Spain. 2003. p. 25.
MacLehose HG, Klaes D, Garner P. What methods do trials use to collect adverse data? In: 11th Cochrane Colloquium: Evidence, Health Care and Culture; 2003 October 26-31; Barcelona, Spain. 2003. p. 56.
MacLehose, H.G. ; Klaes, D. ; Garner, P. Overcoming difficulties with extracting adverse event data. In 11th Cochrane Colloquium: Evidence, Health Care and Culture, 2003 October 26-31; Barcelona, Spain. 2003. p. 56
9th Annual Cochrane Colloquium 2001
Ioannidis JPA, Chew P, Lau J. Standardized retrieval of side effects data for meta-analysis: a feasibility study in acute sinusitis. In: 9th Annual Cochrane Colloquium; 2001 October; Lyon, France. 2001. Available from: http://www.biomedcentral.com/abstracts/COCHRANE/1/op050/
Loke YK, Derry S. Lack of detail and uniformity in the reporting of adverse drug reactions in randomized controlled trials: important implications for systematic reviews. In: 9th Annual Cochrane Colloquium 2001 October; Lyon, France. 2001. Available from: http://www.biomedcentral.com/abstracts/COCHRANE/1/op052/
Smith LA, Deeks JJ. Should case-control studies be included in systematic reviews of the effects of healthcare interventions? In: 9th Annual Cochrane Colloquium 2001 October; Lyon, France. 2001. Available from: http://www.biomedcentral.com/abstracts/COCHRANE/1/op036/
Zhang WY. Evidence from case-control and cohort studies for adverse drug reaction - a case study of analgesic nephropathy. In: 9th Annual Cochrane Colloquium 2001 October; Lyon, France. 2001. Available from: http://www.biomedcentral.com/abstracts/COCHRANE/1/pc149/
8th Annual Cochrane Colloquium 2000
Cosmi B, Castelvetri C, Milandri M, Rubboli A, Confoti A. The evaluation of rare adverse drug events in Cochrane reviews: the incidence of thrombotic thrombocytopenic purpura after ticlopidine plus aspirin for coronary stenting. In: 8th Annual Cochrane Colloquium; 2000 October; Cape Town, South Africa. 2000. Available from: http://www.cochrane.org/colloquia/abstracts/capetown/capetownPA13.html
Craig J, Irwig L. Evaluating both benefits and harms of interventions: the need for equality In: 8th Annual Cochrane Colloquium; 2000; Cape Town, South Africa. 2000. Available from: http://www.cochrane.org/colloquia/abstracts/capetown/capetowno38.html
Hayden M, Pignone M, Phillips C, Mulrow C. Aspirin Chemoprophylaxis: Weighing the benefits and harms for patients at different levels Of risk for cardiovascular disease. In: 8th Annual Cochrane Colloquium; 2000; Cape Town, South Africa. 2000. Available from: http://www.cochrane.org/colloquia/abstracts/capetown/capetownPA14.html
Li Wan Po A, Herxheimer A, Poolsup N, Aziz Z. How do Cochrane reviewers address adverse effects of drug therapy? In: 8th Annual Cochrane Colloquium; 2000 October Cape Town, South Africa. 2000. Available from: http://www.cochrane.org/colloquia/abstracts/capetown/capetowno39.html
7th Annual Cochrane Colloquium 1999
Badgett R, Chiquette E, Anagnostelis B, Mulrow C. Locating reports of serious adverse drug reactions. In: 7th Annual Cochrane Colloquium 1999 October; Rome. 1999. p. PB54. Available from: http://www.cochrane.org/colloquia/abstracts/rome/romePB54.htm
Croft A, Garner P. Travelling to the tropics? How to enrich a systematic review with good observational evidence about adverse effects. In: 7th Annual Cochrane Colloquium; 1999 October; Rome, Italy. 1999. Available from: http://www.cochrane.org/colloquia/abstracts/rome/romeO19.htm
Loke YK, Edwards J, Deny S. Conventional search strategies cannot easily identify those trials of drug therapy which provide quantitative adverse effects data. In: 7th Annual Cochrane Colloquium; 1999 October; Rome. 1999. p. A19 (poster). Available from: http://www.cochrane.org/colloquia/abstracts/rome/romePA19.htm
6th Annual Cochrane Colloquium 1998
Edwards JE, McQuay HJ, Moore RA, Collins SL. Guidelines for reporting adverse effects in clinical trials should be improved - lessons from acute pain. In: 6th Annual Cochrane Colloquium; 1998 October 22-26; Baltimore, MD, USA. 1998. p. 60. Available from: http://www.cochrane.org/colloquia/abstracts/baltimore/MarylandA05.htm
2nd International Conference Scientific Basis of Health Services & 5th Annual Cochrane Colloquium 1997
Bastian H, Middleton P. More good than harm: how well can Cochrane Reviews help people decide? In: 2nd International Conference Scientific Basis of Health Services & 5th Annual Cochrane Colloquium; 1997 October 8-12; Amsterdam, The Netherlands. 1997. p. 91. Available from: http://www.cochrane.org/colloquia/abstracts/amsterdam/Amsterdam971802.htm
*********************************************************************************************************************